Report overview
Decongestant is a type of pharmaceutical drug that is used to relieve nasal congestion in the upper respiratory tract. The active ingredient in most decongestants is either pseudoephedrine or phenylephrine.
This report contains market size and forecasts of Decongestant in global, including the following market information:
Global Decongestant Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Decongestant Market Sales, 2017-2022, 2023-2028, (MT)
Global top five Decongestant companies in 2021 (%)
The global Decongestant market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Tablets Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Decongestant include Mylan N.V., Teva Pharmaceutical Industries Ltd., Ranbaxy Laboratories Ltd., Beximco Pharmaceuticals Ltd., Novartis AG and Cipla Ltd., etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Decongestant manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Decongestant Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Decongestant Market Segment Percentages, by Type, 2021 (%)
Tablets
Capsules
Nasal Sprays
Global Decongestant Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Decongestant Market Segment Percentages, by Application, 2021 (%)
Hospitals
Research & Academic Laboratories
Clinic
Other
Global Decongestant Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Decongestant Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Decongestant revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Decongestant revenues share in global market, 2021 (%)
Key companies Decongestant sales in global market, 2017-2022 (Estimated), (MT)
Key companies Decongestant sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Mylan N.V.
Teva Pharmaceutical Industries Ltd.
Ranbaxy Laboratories Ltd.
Beximco Pharmaceuticals Ltd.
Novartis AG
Cipla Ltd.
